Mindfulness: brain gains and risks
MRI work (Sara Lazar’s team) shows eight weeks of mindfulness can thicken prefrontal cortex and shrink the amygdala — structural changes tied to better focus and emotion regulation. But investigative reports and clinical reviews also document adverse reactions in some practitioners and call for careful monitoring, especially when scaled into staff‑wellbeing programs. (x.com, tvazteca.com, x.com)
A controlled longitudinal MBSR study (n=16 in the training arm, n=17 waitlist) reported pre‑to‑post increases in left hippocampal gray‑matter and whole‑brain increases in posterior cingulate, temporo‑parietal junction and cerebellum after eight weeks. (doi.org) Sara W. Lazar’s early cross‑sectional neuroimaging work was published in NeuroReport (2005) and compared long‑term meditators to matched controls with structural MRI across 20 experienced practitioners. (europepmc.org) A large, preregistered combined randomized trial (n=218) published in Science Advances (2022) found no evidence that 8‑week MBSR produced reproducible changes in gray‑matter volume, density, or cortical thickness versus active or waitlist controls. (science.org) A recent narrative review of structural and functional MRI studies (screening 586 records and retaining 27 studies from 2009–2024) concluded findings are heterogeneous across methods, brain measures and study quality, highlighting both positive small‑sample reports and larger null trials. (sciencedirect.com) A systematic review of 83 studies (6,703 participants) in Acta Psychiatrica Scandinavica reported an overall meditation‑related adverse‑event prevalence of 8.3% (95% CI 5–12%), with anxiety, depression and cognitive anomalies among the most commonly documented categories. (onlinelibrary.wiley.com) A prospective harms‑measurement study of 96 participants in 8‑week mindfulness‑based programs used the 44‑item MedEx‑I and found 83% reported at least one meditation‑related experience, 58% reported negatively‑valenced side effects, 37% reported impacts on functioning, and 6–14% reported lasting bad effects linked to dysregulated arousal. (doi.org) Workplace surveys and meta‑analyses document rapid corporate rollout—about half to ~60% of mid‑to‑large US employers reported offering mindfulness/yoga/meditation by 2018—and multiple implementation reviews urge routine screening, harms monitoring and context‑sensitive program design when MBPs are scaled into staff wellbeing. (link.springer.com)
